Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

Acquired byPfizer
Date9/2010

General Information

Offices

Cambridge, USA
100 Acorn Park Drive
5th Floor
Cambridge, MA, 02140
USA

People

President and CEO
Board Member
Investor

Funding

Tags

Foldrx Pharmaceuticals

FoldRx Pharmaceuticals, Inc. engages in the discovery and development of disease modifying drug therapies for diseases of protein misfolding and amyloidosis. The companyТs pipeline includes a program in advanced clinical development to treat genetic neurologic and cardiovascular disorders, transthyretin-associated amyloidoses with polyneuropathy and TTR-associated amyloidoses with cardiomyopathy, and a discovery program in Parkinson’s disease and cystic fibrosis. FoldRx Pharmaceuticals, Inc. was founded in 2003 and is based in Cambridge, Massachusetts.

Recent Milestones

Videos

Screenshots

Sources

  1. Pfizer To Acquire FoldRx Pharmaceuticals (foldrx.com) [edit]
  2. FoldRx banks $29M for neurodegenerative drug application (fiercebiotech.com) [edit]
Edit This Page
Last Edited 10/27/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy